CASSIDY & ASSOCIATES, INC.

Lobbying for SEQIRUS USA INC · Pharmaceutical Manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income · posted Apr 16, 2026

Lobbying activity 3

Budget/Appropriations

FY27 Appropriations

Defense

FY27 National Defense Authorization Act

Veterans

FY27 National Defense Authorization and FY27 Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.